Finance

Lists
0512:HKG
Grand Pharmaceutical Group Ltd
4,59 HK$
-0,86%
(-0,040) 1D
16 հոկ, 16:08:14 GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 0512...
Open
4,70 HK$
High
4,74 HK$
Low
4,57 HK$
Mkt. cap
16,29 մլրդ
Avg. vol.
3,85 մլն
Volume
3,30 մլն
Dividend
3,68%
Quarterly dividend
0,04 HK$
Ex-dividend date
14 ապր, 2025 թ.
P/E ratio
14,18
52-wk high
8,97 HK$
52-wk low
4,53 HK$
EPS
0,32 HK$
Shares outstanding
3,13 մլրդ
No. of employees
12 հզր
Open
4,70 HK$
High
4,74 HK$
Low
4,57 HK$
Mkt. cap
16,29 մլրդ
Avg. vol.
3,85 մլն
Volume
3,30 մլն
Dividend
3,68%
Quarterly dividend
0,04 HK$
Ex-dividend date
14 ապր, 2025 թ.
P/E ratio
14,18
52-wk high
8,97 HK$
52-wk low
4,53 HK$
EPS
0,32 HK$
Shares outstanding
3,13 մլրդ
No. of employees
12 հզր
News stories
From web sources and news partners
About Grand Pharmaceutical Group Ltd
CEO-
Employees12,3 հզր
Founded1995
Headquarters-
Sector-
Previous reportsAll values in HKD
Loading Previous Earnings...
Revenue
Net income
All values in HKD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
3,09 մլրդ
3,09 մլրդ
3,19 մլրդ
3,19 մլրդ
Cost of goods sold
1,50 մլրդ
1,50 մլրդ
1,51 մլրդ
1,51 մլրդ
Cost of revenue
1,50 մլրդ
1,50 մլրդ
1,51 մլրդ
1,51 մլրդ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,29 մլրդ
1,29 մլրդ
1,13 մլրդ
1,13 մլրդ
Operating expense
1,30 մլրդ
1,30 մլրդ
1,10 մլրդ
1,10 մլրդ
Total operating expenses
2,80 մլրդ
2,80 մլրդ
2,61 մլրդ
2,61 մլրդ
Operating income
285,60 մլն
285,60 մլն
581,07 մլն
581,07 մլն
Other non operating income
449,50 հզր
449,50 հզր
-
-
EBT including unusual items
73,09 մլն
73,09 մլն
629,04 մլն
629,04 մլն
EBT excluding unusual items
257,79 մլն
257,79 մլն
571,85 մլն
571,85 մլն
Income tax expense
37,88 մլն
37,88 մլն
94,74 մլն
94,74 մլն
Effective tax rate
51,82%
51,82%
15,06%
15,06%
Other operating expenses
-8,97 մլն
-8,97 մլն
-22,46 մլն
-22,46 մլն
Net income
35,93 մլն
35,93 մլն
530,77 մլն
530,77 մլն
Net profit margin
1,16%
1,16%
16,62%
16,62%
Earnings per share
-
-
-
-
Interest and investment income
3,68 մլն
3,68 մլն
-
-
Interest expense
-40,99 մլն
-40,99 մլն
-38,38 մլն
-38,38 մլն
Net interest expenses
-37,31 մլն
-37,31 մլն
-38,38 մլն
-38,38 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
426,70 մլն
426,70 մլն
747,52 մլն
747,52 մլն
Gain or loss from assets sale
588,50 հզր
588,50 հզր
-
-
AI content may include mistakes. Learn more
Google Apps